Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Neutral Rating on Biohaven Pharma (BHVN)
-
-
-
-
-
-
-
Jury awards Biohaven and Yale $4M in trade secret case
-
-
-
-
-
-
-
Raymond James on Biohaven Pharma (BHVN) with shares up 7%: 'Promising Degrader Data Sets Ahead of R&D Day'
-
-
-
-
-
-
-
Biohaven Pharma (BHVN) PT Raised to $17 at Citi
-
-
-
-
-
-
-
Biohaven Pharma (BHVN) Tops Q4 EPS by 28c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Neutral Rating on Biohaven Pharmaceutical Holding (BHVN)
-
-
-
-
-
-
-
William Blair Reiterates Market Perform Rating on Biohaven Pharmaceutical Holding (BHVN)
-
452,788 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

